Natural Killer Cell Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data
Report Summary
Natural Killer Cell Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Natural Killer Cell Therapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Natural Killer Cell Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Natural Killer Cell Therapy worldwide and market share by regions, with company and product introduction, position in the Natural Killer Cell Therapy market
Market status and development trend of Natural Killer Cell Therapy by types and applications
Cost and profit status of Natural Killer Cell Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Natural Killer Cell Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Natural Killer Cell Therapy industry.
The report segments the global Natural Killer Cell Therapy market as:
Global Natural Killer Cell Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Natural Killer Cell Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
NK Cell Therapies
NK Cell Directed Antibodies
Global Natural Killer Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Cancer
Gastrointestinal Diseases
Others
Global Natural Killer Cell Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Natural Killer Cell Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Natural Killer Cell Therapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Natural Killer Cell Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Natural Killer Cell Therapy worldwide and market share by regions, with company and product introduction, position in the Natural Killer Cell Therapy market
Market status and development trend of Natural Killer Cell Therapy by types and applications
Cost and profit status of Natural Killer Cell Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Natural Killer Cell Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Natural Killer Cell Therapy industry.
The report segments the global Natural Killer Cell Therapy market as:
Global Natural Killer Cell Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Natural Killer Cell Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
NK Cell Therapies
NK Cell Directed Antibodies
Global Natural Killer Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Cancer
Gastrointestinal Diseases
Others
Global Natural Killer Cell Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NATURAL KILLER CELL THERAPY
1.1 Definition of Natural Killer Cell Therapy in This Report
1.2 Commercial Types of Natural Killer Cell Therapy
1.2.1 NK Cell Therapies
1.2.2 NK Cell Directed Antibodies
1.3 Downstream Application of Natural Killer Cell Therapy
1.3.1 Cancer
1.3.2 Gastrointestinal Diseases
1.3.3 Others
1.4 Development History of Natural Killer Cell Therapy
1.5 Market Status and Trend of Natural Killer Cell Therapy 2016-2026
1.5.1 Global Natural Killer Cell Therapy Market Status and Trend 2016-2026
1.5.2 Regional Natural Killer Cell Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Natural Killer Cell Therapy 2016-2021
2.2 Sales Market of Natural Killer Cell Therapy by Regions
2.2.1 Sales Volume of Natural Killer Cell Therapy by Regions
2.2.2 Sales Value of Natural Killer Cell Therapy by Regions
2.3 Production Market of Natural Killer Cell Therapy by Regions
2.4 Global Market Forecast of Natural Killer Cell Therapy 2022-2026
2.4.1 Global Market Forecast of Natural Killer Cell Therapy 2022-2026
2.4.2 Market Forecast of Natural Killer Cell Therapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Natural Killer Cell Therapy by Types
3.2 Sales Value of Natural Killer Cell Therapy by Types
3.3 Market Forecast of Natural Killer Cell Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Natural Killer Cell Therapy by Downstream Industry
4.2 Global Market Forecast of Natural Killer Cell Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Natural Killer Cell Therapy Market Status by Countries
5.1.1 North America Natural Killer Cell Therapy Sales by Countries (2016-2021)
5.1.2 North America Natural Killer Cell Therapy Revenue by Countries (2016-2021)
5.1.3 United States Natural Killer Cell Therapy Market Status (2016-2021)
5.1.4 Canada Natural Killer Cell Therapy Market Status (2016-2021)
5.1.5 Mexico Natural Killer Cell Therapy Market Status (2016-2021)
5.2 North America Natural Killer Cell Therapy Market Status by Manufacturers
5.3 North America Natural Killer Cell Therapy Market Status by Type (2016-2021)
5.3.1 North America Natural Killer Cell Therapy Sales by Type (2016-2021)
5.3.2 North America Natural Killer Cell Therapy Revenue by Type (2016-2021)
5.4 North America Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Natural Killer Cell Therapy Market Status by Countries
6.1.1 Europe Natural Killer Cell Therapy Sales by Countries (2016-2021)
6.1.2 Europe Natural Killer Cell Therapy Revenue by Countries (2016-2021)
6.1.3 Germany Natural Killer Cell Therapy Market Status (2016-2021)
6.1.4 UK Natural Killer Cell Therapy Market Status (2016-2021)
6.1.5 France Natural Killer Cell Therapy Market Status (2016-2021)
6.1.6 Italy Natural Killer Cell Therapy Market Status (2016-2021)
6.1.7 Russia Natural Killer Cell Therapy Market Status (2016-2021)
6.1.8 Spain Natural Killer Cell Therapy Market Status (2016-2021)
6.1.9 Benelux Natural Killer Cell Therapy Market Status (2016-2021)
6.2 Europe Natural Killer Cell Therapy Market Status by Manufacturers
6.3 Europe Natural Killer Cell Therapy Market Status by Type (2016-2021)
6.3.1 Europe Natural Killer Cell Therapy Sales by Type (2016-2021)
6.3.2 Europe Natural Killer Cell Therapy Revenue by Type (2016-2021)
6.4 Europe Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Natural Killer Cell Therapy Market Status by Countries
7.1.1 Asia Pacific Natural Killer Cell Therapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Natural Killer Cell Therapy Revenue by Countries (2016-2021)
7.1.3 China Natural Killer Cell Therapy Market Status (2016-2021)
7.1.4 Japan Natural Killer Cell Therapy Market Status (2016-2021)
7.1.5 India Natural Killer Cell Therapy Market Status (2016-2021)
7.1.6 Southeast Asia Natural Killer Cell Therapy Market Status (2016-2021)
7.1.7 Australia Natural Killer Cell Therapy Market Status (2016-2021)
7.2 Asia Pacific Natural Killer Cell Therapy Market Status by Manufacturers
7.3 Asia Pacific Natural Killer Cell Therapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Natural Killer Cell Therapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Natural Killer Cell Therapy Revenue by Type (2016-2021)
7.4 Asia Pacific Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Natural Killer Cell Therapy Market Status by Countries
8.1.1 Latin America Natural Killer Cell Therapy Sales by Countries (2016-2021)
8.1.2 Latin America Natural Killer Cell Therapy Revenue by Countries (2016-2021)
8.1.3 Brazil Natural Killer Cell Therapy Market Status (2016-2021)
8.1.4 Argentina Natural Killer Cell Therapy Market Status (2016-2021)
8.1.5 Colombia Natural Killer Cell Therapy Market Status (2016-2021)
8.2 Latin America Natural Killer Cell Therapy Market Status by Manufacturers
8.3 Latin America Natural Killer Cell Therapy Market Status by Type (2016-2021)
8.3.1 Latin America Natural Killer Cell Therapy Sales by Type (2016-2021)
8.3.2 Latin America Natural Killer Cell Therapy Revenue by Type (2016-2021)
8.4 Latin America Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Natural Killer Cell Therapy Market Status by Countries
9.1.1 Middle East and Africa Natural Killer Cell Therapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Natural Killer Cell Therapy Revenue by Countries (2016-2021)
9.1.3 Middle East Natural Killer Cell Therapy Market Status (2016-2021)
9.1.4 Africa Natural Killer Cell Therapy Market Status (2016-2021)
9.2 Middle East and Africa Natural Killer Cell Therapy Market Status by Manufacturers
9.3 Middle East and Africa Natural Killer Cell Therapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Natural Killer Cell Therapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Natural Killer Cell Therapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NATURAL KILLER CELL THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Natural Killer Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 NATURAL KILLER CELL THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Natural Killer Cell Therapy by Major Manufacturers
11.2 Production Value of Natural Killer Cell Therapy by Major Manufacturers
11.3 Basic Information of Natural Killer Cell Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Natural Killer Cell Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Natural Killer Cell Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NATURAL KILLER CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Nektar Therapeutics
12.1.1 Company profile
12.1.2 Representative Natural Killer Cell Therapy Product
12.1.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nektar Therapeutics
12.2 Innate Pharma SA
12.2.1 Company profile
12.2.2 Representative Natural Killer Cell Therapy Product
12.2.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Innate Pharma SA
12.3 Affimed
12.3.1 Company profile
12.3.2 Representative Natural Killer Cell Therapy Product
12.3.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Affimed
12.4 Chipscreen Biosciences
12.4.1 Company profile
12.4.2 Representative Natural Killer Cell Therapy Product
12.4.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences
12.5 Glycostem Therapeutics
12.5.1 Company profile
12.5.2 Representative Natural Killer Cell Therapy Product
12.5.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Glycostem Therapeutics
12.6 Fate Therapeutics
12.6.1 Company profile
12.6.2 Representative Natural Killer Cell Therapy Product
12.6.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Fate Therapeutics
12.7 Dragonfly Therapeutics
12.7.1 Company profile
12.7.2 Representative Natural Killer Cell Therapy Product
12.7.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Dragonfly Therapeutics
12.8 Kiadis Pharma
12.8.1 Company profile
12.8.2 Representative Natural Killer Cell Therapy Product
12.8.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Kiadis Pharma
12.9 Nkarta Therapeutics
12.9.1 Company profile
12.9.2 Representative Natural Killer Cell Therapy Product
12.9.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nkarta Therapeutics
12.10 NantKwest
12.10.1 Company profile
12.10.2 Representative Natural Killer Cell Therapy Product
12.10.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of NantKwest
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NATURAL KILLER CELL THERAPY
13.1 Industry Chain of Natural Killer Cell Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NATURAL KILLER CELL THERAPY
14.1 Cost Structure Analysis of Natural Killer Cell Therapy
14.2 Raw Materials Cost Analysis of Natural Killer Cell Therapy
14.3 Labor Cost Analysis of Natural Killer Cell Therapy
14.4 Manufacturing Expenses Analysis of Natural Killer Cell Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Natural Killer Cell Therapy in This Report
1.2 Commercial Types of Natural Killer Cell Therapy
1.2.1 NK Cell Therapies
1.2.2 NK Cell Directed Antibodies
1.3 Downstream Application of Natural Killer Cell Therapy
1.3.1 Cancer
1.3.2 Gastrointestinal Diseases
1.3.3 Others
1.4 Development History of Natural Killer Cell Therapy
1.5 Market Status and Trend of Natural Killer Cell Therapy 2016-2026
1.5.1 Global Natural Killer Cell Therapy Market Status and Trend 2016-2026
1.5.2 Regional Natural Killer Cell Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Natural Killer Cell Therapy 2016-2021
2.2 Sales Market of Natural Killer Cell Therapy by Regions
2.2.1 Sales Volume of Natural Killer Cell Therapy by Regions
2.2.2 Sales Value of Natural Killer Cell Therapy by Regions
2.3 Production Market of Natural Killer Cell Therapy by Regions
2.4 Global Market Forecast of Natural Killer Cell Therapy 2022-2026
2.4.1 Global Market Forecast of Natural Killer Cell Therapy 2022-2026
2.4.2 Market Forecast of Natural Killer Cell Therapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Natural Killer Cell Therapy by Types
3.2 Sales Value of Natural Killer Cell Therapy by Types
3.3 Market Forecast of Natural Killer Cell Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Natural Killer Cell Therapy by Downstream Industry
4.2 Global Market Forecast of Natural Killer Cell Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Natural Killer Cell Therapy Market Status by Countries
5.1.1 North America Natural Killer Cell Therapy Sales by Countries (2016-2021)
5.1.2 North America Natural Killer Cell Therapy Revenue by Countries (2016-2021)
5.1.3 United States Natural Killer Cell Therapy Market Status (2016-2021)
5.1.4 Canada Natural Killer Cell Therapy Market Status (2016-2021)
5.1.5 Mexico Natural Killer Cell Therapy Market Status (2016-2021)
5.2 North America Natural Killer Cell Therapy Market Status by Manufacturers
5.3 North America Natural Killer Cell Therapy Market Status by Type (2016-2021)
5.3.1 North America Natural Killer Cell Therapy Sales by Type (2016-2021)
5.3.2 North America Natural Killer Cell Therapy Revenue by Type (2016-2021)
5.4 North America Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Natural Killer Cell Therapy Market Status by Countries
6.1.1 Europe Natural Killer Cell Therapy Sales by Countries (2016-2021)
6.1.2 Europe Natural Killer Cell Therapy Revenue by Countries (2016-2021)
6.1.3 Germany Natural Killer Cell Therapy Market Status (2016-2021)
6.1.4 UK Natural Killer Cell Therapy Market Status (2016-2021)
6.1.5 France Natural Killer Cell Therapy Market Status (2016-2021)
6.1.6 Italy Natural Killer Cell Therapy Market Status (2016-2021)
6.1.7 Russia Natural Killer Cell Therapy Market Status (2016-2021)
6.1.8 Spain Natural Killer Cell Therapy Market Status (2016-2021)
6.1.9 Benelux Natural Killer Cell Therapy Market Status (2016-2021)
6.2 Europe Natural Killer Cell Therapy Market Status by Manufacturers
6.3 Europe Natural Killer Cell Therapy Market Status by Type (2016-2021)
6.3.1 Europe Natural Killer Cell Therapy Sales by Type (2016-2021)
6.3.2 Europe Natural Killer Cell Therapy Revenue by Type (2016-2021)
6.4 Europe Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Natural Killer Cell Therapy Market Status by Countries
7.1.1 Asia Pacific Natural Killer Cell Therapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Natural Killer Cell Therapy Revenue by Countries (2016-2021)
7.1.3 China Natural Killer Cell Therapy Market Status (2016-2021)
7.1.4 Japan Natural Killer Cell Therapy Market Status (2016-2021)
7.1.5 India Natural Killer Cell Therapy Market Status (2016-2021)
7.1.6 Southeast Asia Natural Killer Cell Therapy Market Status (2016-2021)
7.1.7 Australia Natural Killer Cell Therapy Market Status (2016-2021)
7.2 Asia Pacific Natural Killer Cell Therapy Market Status by Manufacturers
7.3 Asia Pacific Natural Killer Cell Therapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Natural Killer Cell Therapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Natural Killer Cell Therapy Revenue by Type (2016-2021)
7.4 Asia Pacific Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Natural Killer Cell Therapy Market Status by Countries
8.1.1 Latin America Natural Killer Cell Therapy Sales by Countries (2016-2021)
8.1.2 Latin America Natural Killer Cell Therapy Revenue by Countries (2016-2021)
8.1.3 Brazil Natural Killer Cell Therapy Market Status (2016-2021)
8.1.4 Argentina Natural Killer Cell Therapy Market Status (2016-2021)
8.1.5 Colombia Natural Killer Cell Therapy Market Status (2016-2021)
8.2 Latin America Natural Killer Cell Therapy Market Status by Manufacturers
8.3 Latin America Natural Killer Cell Therapy Market Status by Type (2016-2021)
8.3.1 Latin America Natural Killer Cell Therapy Sales by Type (2016-2021)
8.3.2 Latin America Natural Killer Cell Therapy Revenue by Type (2016-2021)
8.4 Latin America Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Natural Killer Cell Therapy Market Status by Countries
9.1.1 Middle East and Africa Natural Killer Cell Therapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Natural Killer Cell Therapy Revenue by Countries (2016-2021)
9.1.3 Middle East Natural Killer Cell Therapy Market Status (2016-2021)
9.1.4 Africa Natural Killer Cell Therapy Market Status (2016-2021)
9.2 Middle East and Africa Natural Killer Cell Therapy Market Status by Manufacturers
9.3 Middle East and Africa Natural Killer Cell Therapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Natural Killer Cell Therapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Natural Killer Cell Therapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Natural Killer Cell Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NATURAL KILLER CELL THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Natural Killer Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 NATURAL KILLER CELL THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Natural Killer Cell Therapy by Major Manufacturers
11.2 Production Value of Natural Killer Cell Therapy by Major Manufacturers
11.3 Basic Information of Natural Killer Cell Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Natural Killer Cell Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Natural Killer Cell Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NATURAL KILLER CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Nektar Therapeutics
12.1.1 Company profile
12.1.2 Representative Natural Killer Cell Therapy Product
12.1.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nektar Therapeutics
12.2 Innate Pharma SA
12.2.1 Company profile
12.2.2 Representative Natural Killer Cell Therapy Product
12.2.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Innate Pharma SA
12.3 Affimed
12.3.1 Company profile
12.3.2 Representative Natural Killer Cell Therapy Product
12.3.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Affimed
12.4 Chipscreen Biosciences
12.4.1 Company profile
12.4.2 Representative Natural Killer Cell Therapy Product
12.4.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences
12.5 Glycostem Therapeutics
12.5.1 Company profile
12.5.2 Representative Natural Killer Cell Therapy Product
12.5.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Glycostem Therapeutics
12.6 Fate Therapeutics
12.6.1 Company profile
12.6.2 Representative Natural Killer Cell Therapy Product
12.6.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Fate Therapeutics
12.7 Dragonfly Therapeutics
12.7.1 Company profile
12.7.2 Representative Natural Killer Cell Therapy Product
12.7.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Dragonfly Therapeutics
12.8 Kiadis Pharma
12.8.1 Company profile
12.8.2 Representative Natural Killer Cell Therapy Product
12.8.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Kiadis Pharma
12.9 Nkarta Therapeutics
12.9.1 Company profile
12.9.2 Representative Natural Killer Cell Therapy Product
12.9.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nkarta Therapeutics
12.10 NantKwest
12.10.1 Company profile
12.10.2 Representative Natural Killer Cell Therapy Product
12.10.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of NantKwest
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NATURAL KILLER CELL THERAPY
13.1 Industry Chain of Natural Killer Cell Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NATURAL KILLER CELL THERAPY
14.1 Cost Structure Analysis of Natural Killer Cell Therapy
14.2 Raw Materials Cost Analysis of Natural Killer Cell Therapy
14.3 Labor Cost Analysis of Natural Killer Cell Therapy
14.4 Manufacturing Expenses Analysis of Natural Killer Cell Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
